Device Week, 20 June 2019: ADA 2019 Key Players; Trial Results From Global Kinetics And Myriad Genetics
Executive Summary
In this edition of Device Week, Medtech Insight's Catherine Longworth chats with Marion Webb about her upcoming Market Intelligence story based on interviews with the biggest players in the diabetes market at the recent annual American Diabetes Association meeting. And Reed Miller discusses Global Kinetics' recent data on its Personal KinetiGraph that can help identify Parkinson's patients most likely to benefit from device-assisted therapy and Myriad Genetics' POLO trial results.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode:
-
ADA Exec Chat: Hiten Chawla Medtronics VP Of Global Marketing Discusses Diabetes Business
-
Glooko Inks Partnership Deal With Companion Medical To Integrate Insulin Pen Data
-
Glooko And T1D Exchange Enter Partnership To Leverage Device Data From Type 1 Diabetes
-
Myriad Foresees Important Role For Genetic Testing In Pancreatic Cancer, Breast Cancer, And Beyond
-
Why Unprecedented Numbers Are Flocking To Brussels In Uncertain Times
-
Lack of Funding Stalls Major US FDA Cybersecurity Initiative